X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3135) 3135
Publication (596) 596
Book Review (76) 76
Book Chapter (27) 27
Conference Proceeding (10) 10
Magazine Article (7) 7
Book / eBook (3) 3
Dissertation (1) 1
Government Document (1) 1
Reference (1) 1
Trade Publication Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2036) 2036
index medicus (1816) 1816
male (1423) 1423
animals (1281) 1281
female (1165) 1165
nicotine (1025) 1025
pharmacology & pharmacy (824) 824
adult (720) 720
neurosciences (718) 718
nicotinic agonists - adverse effects (716) 716
smoking (675) 675
smoking cessation - methods (608) 608
nicotinic agonists - therapeutic use (587) 587
middle aged (566) 566
nicotinic agonists - administration & dosage (562) 562
rats (556) 556
nicotine - adverse effects (551) 551
smoking cessation (551) 551
nicotinic agonists - pharmacology (535) 535
varenicline (526) 526
psychiatry (520) 520
nicotine - administration & dosage (499) 499
nicotine - pharmacology (472) 472
article (421) 421
smoking - adverse effects (399) 399
receptors, nicotinic - metabolism (385) 385
cigarette-smoking (362) 362
dose-response relationship, drug (356) 356
mice (353) 353
treatment outcome (351) 351
tobacco (309) 309
smoking cessation programs (275) 275
analysis (267) 267
smokers (261) 261
nicotinic acetylcholine-receptors (260) 260
substance abuse (256) 256
double-blind method (252) 252
rats, sprague-dawley (252) 252
time factors (250) 250
aged (245) 245
smoking-cessation (245) 245
benzazepines - therapeutic use (239) 239
nicotine - therapeutic use (238) 238
quinoxalines - therapeutic use (236) 236
adolescent (228) 228
receptors, nicotinic - drug effects (228) 228
risk factors (226) 226
young adult (226) 226
receptor partial agonist (224) 224
research (223) 223
benzazepines - adverse effects (217) 217
quinoxalines - adverse effects (216) 216
sustained-release bupropion (216) 216
pregnancy (210) 210
nicotine replacement therapy (204) 204
health aspects (200) 200
medicine, general & internal (199) 199
brain (198) 198
schizophrenia (198) 198
smoking prevention (196) 196
cessation (195) 195
toxicology (182) 182
smoking - psychology (179) 179
tobacco use disorder - drug therapy (177) 177
nicotinic receptors (176) 176
disease models, animal (172) 172
care and treatment (171) 171
acetylcholine-receptors (169) 169
bupropion - therapeutic use (169) 169
efficacy (169) 169
dependence (167) 167
brain - drug effects (163) 163
receptors (162) 162
acetylcholine receptors (157) 157
double-blind (156) 156
smoking - drug therapy (156) 156
nicotinic antagonists - pharmacology (151) 151
acetylcholine (149) 149
clinical neurology (148) 148
drug therapy (148) 148
bupropion (146) 146
administration, cutaneous (141) 141
randomized controlled-trial (141) 141
nicotinic acetylcholine-receptor (140) 140
alzheimers-disease (139) 139
addiction (137) 137
smoking cessation - psychology (136) 136
pharmacotherapy (135) 135
rats, wistar (133) 133
biomedicine (130) 130
abridged index medicus (129) 129
transdermal nicotine (129) 129
brain - metabolism (128) 128
pharmacology/toxicology (127) 127
rodents (124) 124
smoking - epidemiology (124) 124
mice, inbred c57bl (121) 121
pharmacology (121) 121
placebo (121) 121
clinical trials (120) 120
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3097) 3097
French (16) 16
Spanish (12) 12
German (8) 8
Dutch (5) 5
Japanese (4) 4
Danish (3) 3
Hungarian (3) 3
Romanian (3) 3
Swedish (3) 3
Polish (2) 2
Russian (2) 2
Chinese (1) 1
Hebrew (1) 1
Italian (1) 1
Portuguese (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cochrane Database of Systematic Reviews, ISSN 1469-493X, 05/2016, Volume 2016, Issue 5, p. CD006103
Background Nicotine receptor partial agonists may help people to stop smoking by a combination of maintaining moderate levels of dopamine to counteract... 
Smoking [drug therapy] | Varenicline | Humans | RANDOMIZED CONTROLLED-TRIAL | Quinolizines [therapeutic use] | PSYCHIATRIC ADVERSE EVENTS | TOBACCO-DEPENDENCE TREATMENT | Quinoxalines [therapeutic use] | MEDICINE, GENERAL & INTERNAL | Bupropion [therapeutic use] | Nicotine [adverse effects; antagonists & inhibitors] | REPLACEMENT THERAPY | SUSTAINED-RELEASE BUPROPION | Smoking Cessation [methods] | Counseling [methods] | VARENICLINE TREATMENT | METHADONE-MAINTAINED SMOKERS | Randomized Controlled Trials as Topic | Azepines [therapeutic use] | DOUBLE-BLIND PLACEBO | Alkaloids [therapeutic use] | Nicotinic Agonists [adverse effects; therapeutic use] | Azocines [therapeutic use] | LONG-TERM SAFETY | Benzazepines [therapeutic use] | PLACEBO-CONTROLLED TRIAL | Substance Withdrawal Syndrome [prevention & control] | Heterocyclic Compounds with 4 or More Rings [therapeutic use] | Quinolizines - therapeutic use | Azepines - adverse effects | Azocines - therapeutic use | Azocines - adverse effects | Substance Withdrawal Syndrome - prevention & control | Alkaloids - adverse effects | Benzazepines - adverse effects | Smoking - drug therapy | Heterocyclic Compounds, 4 or More Rings - adverse effects | Nicotinic Agonists - therapeutic use | Nicotine - antagonists & inhibitors | Smoking Cessation - methods | Azepines - therapeutic use | Nicotine - adverse effects | Nicotinic Agonists - adverse effects | Heterocyclic Compounds, 4 or More Rings - therapeutic use | Benzazepines - therapeutic use | Counseling - methods | Alkaloids - therapeutic use | Quinolizines - adverse effects | Varenicline - therapeutic use | Bupropion - therapeutic use
Journal Article
Cochrane database of systematic reviews (Online), ISSN 1469-493X, 2012, Volume 4, Issue 4, p. CD006103
Journal Article
Journal Article
Journal Article
Journal Article
Circulation, ISSN 0009-7322, 01/2014, Volume 129, Issue 1, pp. 28 - 41
Journal Article